Literature DB >> 15223091

Identifying pregnant women at risk for early attrition from substance abuse treatment.

Wendy B Kissin1, Dace S Svikis, Paula Moylan, Nancy A Haug, Maxine L Stitzer.   

Abstract

Greater treatment retention among pregnant substance abusers is associated with improved pregnancy and neonatal outcomes, so early identification of clients most at risk for early attrition is essential. Participants were 152 pregnant women enrolled in the initial 7-day residential component of a comprehensive substance abuse treatment program for pregnant women. Twenty-nine (19%) women left treatment within the first 5 days, primarily within the first 2 days. Clinical staff identified many, but not all, patients who eventually left treatment early as many indicated their desire to leave and were troubled by drug craving and withdrawal. Other predictors of attrition included not receiving methadone maintenance, being Caucasian, and reporting more prior drug treatment episodes, fewer medical problems and, to a lesser extent, more family/social and psychiatric and fewer drug problems on the Addiction Severity Index. Interventions are needed to target pregnant clients most at risk for early treatment attrition.

Entities:  

Mesh:

Year:  2004        PMID: 15223091     DOI: 10.1016/j.jsat.2004.03.007

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  15 in total

1.  Alcohol use during pregnancy: prevalence and impact.

Authors:  Chaya G Bhuvaneswar; Grace Chang; Lucy A Epstein; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

2.  Pregnancy and race/ethnicity as predictors of motivation for drug treatment.

Authors:  Mary M Mitchell; S Geoff Severtson; William W Latimer
Journal:  Am J Drug Alcohol Abuse       Date:  2008       Impact factor: 3.829

3.  Comparison of the Addiction Severity Index (ASI) and the Global Appraisal of Individual Needs (GAIN) in predicting the effectiveness of drug treatment programs for pregnant and postpartum women.

Authors:  Victoria H Coleman-Cowger; Michael L Dennis; Rodney R Funk; Susan H Godley; Richard D Lennox
Journal:  J Subst Abuse Treat       Date:  2012-03-20

4.  Addiction severity index composite scores as predictors for sexual-risk behaviors and drug-use behaviors in drug-using pregnant patients.

Authors:  R Chaudhury; H E Jones; W Wechsberg; K E O'Grady; M Tuten; M S Chisolm
Journal:  Am J Drug Alcohol Abuse       Date:  2010-01       Impact factor: 3.829

5.  Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs.

Authors:  Yih-Ing Hser; Elizabeth Evans; David Huang; Nena Messina
Journal:  J Subst Abuse Treat       Date:  2011-04-05

6.  Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study.

Authors:  Susan M Stine; Sarah H Heil; Karol Kaltenbach; Peter R Martin; Mara G Coyle; Gabriele Fischer; Amelia M Arria; Peter Selby; Hendree E Jones
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

7.  Relationship between cigarette use and mood/anxiety disorders among pregnant methadone-maintained patients.

Authors:  Margaret S Chisolm; Michelle Tuten; Emily C Brigham; Eric C Strain; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Sep-Oct

8.  Family discord is associated with increased substance use for pregnant substance users.

Authors:  Wayne H Denton; Bryon H Adinoff; Daniel Lewis; Robrina Walker; Theresa Winhusen
Journal:  Subst Use Misuse       Date:  2013-10-09       Impact factor: 2.164

9.  Predictors of dropout from psychosocial treatment in opioid-dependent outpatients.

Authors:  R Kathryn McHugh; Heather W Murray; Bridget A Hearon; Elizabeth M Pratt; Mark H Pollack; Steven A Safren; Michael W Otto
Journal:  Am J Addict       Date:  2013-01

Review 10.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.